Integrated oral microgel system ameliorates renal fibrosis by hitchhiking co-delivery and targeted gut flora modulation

Yu Hou,Lin Zhu,Xiaofeng Ye,Qiaoying Ke,Qibin Zhang,Xiaowei Xie,Ji-gang Piao,Yinghui Wei
DOI: https://doi.org/10.1186/s12951-024-02586-2
IF: 10.2
2024-06-02
Journal of Nanobiotechnology
Abstract:Renal fibrosis is a progressive process associated with chronic kidney disease (CKD), contributing to impaired kidney function. Active constituents in traditional Chinese herbs, such as emodin (EMO) and asiatic acid (AA), exhibit potent anti-fibrotic properties. However, the oral administration of EMO and AA results in low bioavailability and limited kidney accumulation. Additionally, while oral probiotics have been accepted for CKD treatment through gut microbiota modulation, a significant challenge lies in ensuring their viability upon administration. Therefore, our study aims to address both renal fibrosis and gut microbiota imbalance through innovative co-delivery strategies.
biotechnology & applied microbiology,nanoscience & nanotechnology
What problem does this paper attempt to address?